SAN DIEGO, April 12, 2012 (GLOBE NEWSWIRE) -- Profil Institute for Clinical Research, Inc., a company leading the industry in early phase clinical trials for diabetes and obesity, comes out in full force for the American Diabetes Association's Tour de Cure each year as a corporate sponsor and also organizer of a team of nearly 40 cyclists – the Profil Peddlers – each fund-raising a minimum of $200 for the event.
Profil Peddler participants are people from all walks of life, many of whom are afflicted by diabetes or supporting others with diabetes and many of whom are employees of the organizer Profil Institute for Clinical Research, headquartered in Chula Vista. What they have in common is a goal of raising as much money as possible to support the American Diabetes Association and to make a difference in the lives of diabetic patients and their families.
"It's really a spectacular experience to be part of this team, and what often feels like a family, that is working toward the common goal of helping others. By making a difference in others' lives, we end up experiencing a positive impact in our own," said Carmen Jany-O, Profil Peddler team captain and Profil Peddler herself since 2010. "As a team we have raised over $10,000 for this year's event."
This year's Tour de Cure will take place Saturday, April 21 beginning at Torrey Pines High School. The Tour de Cure, a fund-raising event with cyclists participating in routes of 10 to 100 miles, attracts more than 55,000 cyclists in 80 events nationwide and raised more than $18 million last year. Funds raised are used to support the mission of the American Diabetes Association to prevent and cure diabetes and to improve the lives of all people affected by the disease.
"Profil Institute is a supporter of the American Diabetes Association in every manner possible. We have the common goal of advancing research to eradicate diabetes," said Claus Hakenesch, Profil Institute's CFO, Tour de Cure Committee member, and a Profil Peddler. "The Tour de Cure is really a spectacular event and is our opportunity to sponsor and volunteer for an event benefiting the American Diabetes Association while training and cycling side by side with the very people for whom our clinical research will hopefully make a significant impact."
For more information about San Diego's Tour de Cure to take place on Saturday, April 21, 2012, visit the website: http://main.diabetes.org/site/TR/TourdeCure/SanDiegoArea?pg=entry&fr_id=8063.
About Profil Institute for Clinical Research, Inc.
Profil Institute's advances in early phase drug research and its specific focus on diabetes, obesity and cardiometabolic diseases as it relates to the diabetic patient population have led Profil Institute to be the most highly regarded clinical research institute for early phase diabetes drug trials.
To date, Profil Institute has been involved with almost every clinically promising drug category and device development in diabetes and in more than 175 clinical studies since the company's inception in 2004. Contributing to Profil Institute's success is that the company is recognized as the leader in automated glucose clamps, considered the "Gold Standard" for the evaluation of anti-diabetic drugs and devices. The company's key scientists hail from academic centers including the WHO Collaborating Center of Diabetes at the Heinrich-Heine University of Düsseldorf, Columbia University, University of Michigan and Harvard University. For more information visit http://www.profilinstitute.com/.
The Profil Institute for Clinical Research, Inc PST logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=12381
Files accompanying this release are available at:
http://media.globenewswire.com/cache/19758/file/13275.jpg
